Lazard Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,014
Closed -$72K 1943
2025
Q3
$72K Sell
17,014
-128
-0.7% -$563 ﹤0.01% 1722
2025
Q2
$85K Buy
17,142
+5,201
+44% +$22.6K ﹤0.01% 1902
2025
Q1
$52K Buy
11,941
+6,285
+111% +$29.5K ﹤0.01% 1984
2024
Q4
$26K Sell
5,656
-51,337
-90% -$282K ﹤0.01% 2052
2024
Q3
$395K Buy
+56,993
New +$447K ﹤0.01% 1429

Other funds holding GDRX

Lazard Asset Management's GDRX Position: Q4 2025 in Review

Lazard Asset Management sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 17,014 shares — an estimated $72K sold.

Lazard Asset Management first reported a position in GDRX in Q3 2024 and held it in 5 quarters. The position peaked at $395K in Q3 2024. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • Lazard Asset Management reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
  • Lazard Asset Management sold 17,014 GoodRx Holdings shares in Q4 2025, an estimated $72K.
  • Lazard Asset Management first reported a position in GoodRx Holdings in Q3 2024 and held it in 5 quarters.
  • Lazard Asset Management's GoodRx Holdings position peaked at $395K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Lazard Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.